JP Morgan Chase
HOWL icon

JP Morgan Chase’s Werewolf Therapeutics HOWL Stock Holding History

JP Morgan Chase’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$650 Buy
2,108
+12
+0.6% +$7 ﹤0.01% 7386
2026
Q1 		$1.67K Buy
2,096
+24
+1% +$16 ﹤0.01% 7048
2025
Q4 		$1.31K Buy
2,072
+949
+85% +$1.15K ﹤0.01% 6998
2025
Q3 		$2.21K Sell
1,123
-9,775
-90% -$13.4K ﹤0.01% 6894
2025
Q2 		$11.9K Sell
10,898
-5,114
-32% -$5.26K ﹤0.01% 6279
2025
Q1 		$15.6K Sell
16,012
-46,916
-75% -$61.4K ﹤0.01% 6215
2024
Q4 		$93.1K Buy
62,928
+49,608
+372% +$101K ﹤0.01% 5786
2024
Q3 		$28.2K Buy
13,320
+245
+2% +$557 ﹤0.01% 6158
2024
Q2 		$31.9K Sell
13,075
-58,109
-82% -$279K ﹤0.01% 6021
2024
Q1 		$461K Buy
71,184
+71,101
+85,664% +$414K ﹤0.01% 4851
2023
Q4 		$320 Sell
83
-665
-89% -$1.7K ﹤0.01% 6996
2023
Q3 		$1.6K Hold
748
– – ﹤0.01% 6579
2023
Q2 		$2.28K Hold
748
– – ﹤0.01% 6313
2023
Q1 		$2K Hold
748
– – ﹤0.01% 6420
2022
Q4 		$2K Sell
748
-752
-50% -$1.97K ﹤0.01% 6312
2022
Q3 		$7K Sell
1,500
-2,198
-59% -$11.9K ﹤0.01% 6026
2022
Q2 		$15K Sell
3,698
-11,929
-76% -$54.4K ﹤0.01% 5951
2022
Q1 		$68K Sell
15,627
-12,430
-44% -$87.1K ﹤0.01% 5673
2021
Q4 		$334K Buy
28,057
+24,209
+629% +$365K ﹤0.01% 5068
2021
Q3 		$66K Sell
3,848
-5,504
-59% -$93.9K ﹤0.01% 5744
2021
Q2 		$163K Buy
+9,352
New +$128K ﹤0.01% 5338

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.25M AUM 26.51% 1-Year Est. Return
VA
Verdad Advisers Boston, Massachusetts $104M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase's HOWL Position: Q2 2026 in Review

JP Morgan Chase increased its Werewolf Therapeutics (HOWL) stake by 0.57% in Q2 2026, buying an estimated $7 and bringing the position to 2,108 shares worth $650. The position accounts for ﹤0.01% of the portfolio, ranked #7386.

JP Morgan Chase first reported a position in HOWL in Q2 2021 and has held it in 21 quarters since. The position peaked at $461K in Q1 2024. 45 funds tracked by Wall St. Rank hold HOWL as of Q2 2026.

  • JP Morgan Chase held 2,108 shares of Werewolf Therapeutics worth $650 as of Q2 2026.
  • JP Morgan Chase bought 12 Werewolf Therapeutics shares in Q2 2026, an estimated $7.
  • Werewolf Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7386 holding.
  • JP Morgan Chase first reported a position in Werewolf Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • JP Morgan Chase's Werewolf Therapeutics position peaked at $461K in Q1 2024.
  • 45 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.